China's Zhejiang Huahai lambasted in FDA warning letter for putting profits ahead of safety
admin 11th December 2018 Uncategorised 0The Chinese API maker at the heart of a global scare and recall of blood pressure medicines has been savaged in an FDA warning letter for failing to uncover a suspected carcinogen in its APIs when a customer complained several years ago.
More: China's Zhejiang Huahai lambasted in FDA warning letter for putting profits ahead of safety
Source: fierce